Questions About the Original Prefilled Pen
separetorPrinter Friendly Version
The following are questions your patients may have about using the original Prefilled Pen.

Insulin does not come out of the needle. What should I do?
To obtain an accurate dose, you must:
  1. Attach a new needle.
  2. Push in the injection button completely (even if a 0 is seen in the window) until a diamond (♦) or an arrow (→) is seen in the center of the dose window.
  3. Prime the Pen.
Note: You may need to prime a new Pen up to six times before a stream of insulin appears.
Back to top

I dialed the wrong dose (too high or too low). How do I correct the problem?
If you have not pushed in the injection button, simply turn the dose knob backward or forward to correct the dose.
Back to top

How much insulin is in the Pen?
Each Pen contains a 3 mL (100U/mL) cartridge, which is filled with enough insulin to ensure the delivery of 300 units.
Back to top

I am not sure how much insulin remains in the cartridge. How do I determine this?
Hold the Pen with the needle end pointing down. The scale on the clear cartridge holder (20 units between marks) shows an estimate of the number of insulin units remaining. These numbers should not be used for measuring an insulin dose.
Back to top

What should I do if my full dose cannot be dialed?
The Pen will not allow you to dial a dose greater than the number of insulin units remaining in the cartridge. For example, if you need 31 units and only 25 units remain in the Pen, you will not be able to dial past 25. Do not attempt to dial past this point. (The insulin that remains is unusable and not part of the 300 units.) If a partial dose remains in the Pen you may either:
  1. Give the partial dose and then give the remaining dose using a new Pen, or
  2. Give the full dose with a new Pen.
Back to top

A small amount of insulin remains in the cartridge, but a dose cannot be dialed. Why?
The Pen design prevents the cartridge from being completely emptied. The Pen has delivered 300 units of usable insulin.
Back to top

What should I do if I cannot completely push in the injection button when priming the Pen or injecting a dose?
  1. Needle is not attached or is clogged.
    1. Attach a new needle.
    2. Push in the injection button completely (even if a "0" is seen in the window) until a diamond (♦) or an arrow (→) is seen in the center of the dose window.
    3. Prime the Pen.
  2. If you are sure insulin is coming out of the needle, push in the injection button more slowly to reduce the effort needed and maintain a constant pressure until the injection button is completely pushed in.
Back to top

Why do I need to prime a new Pen up to six times?
The first time you use a new Pen, priming up to six times may be needed to see a stream of insulin come out of the tip of the needle. If you do not prime until you see a stream of insulin, you may get too much or too little insulin.
Back to top

How and where should I store my Pen? Humalog Pens should be discarded 28 days after first use. Humalog Mix75/25 and Humalog Mix50/50 Pens should be discarded 10 days after first use. Be sure to also check the expiration date printed on the Prefilled Pen's label. The date must allow enough time for you to use all the insulin in the Pen.
Back to top

Send to a Colleague
Next Page

Indication
Humalog (insulin lispro injection [rDNA origin]), Humalog Mix75/25 (75% insulin lispro protamine suspension, 25% insulin lispro injection [rDNA origin]), and Humalog Mix50/50 (50% insulin lispro protamine suspension, 50% insulin lispro injection [rDNA origin]) are for use in patients with diabetes mellitus for the control of hyperglycemia. Humalog should be used with longer-acting insulin, except when used in combination with sulfonylureas in patients with type 2 diabetes.

Humalog insulins are contraindicated during episodes of hypoglycemia and in patients sensitive to Humalog or one of its excipients.

Important Safety Information
Humalog differs from regular human insulin by its rapid onset of action as well as a shorter duration of action. Therefore, when used as a mealtime insulin, Humalog insulins (Humalog, Humalog Mix75/25, and Humalog Mix50/50) should be given within 15 minutes before a meal. Humalog can also be given immediately after a meal.

Important Safety Information
Humalog insulins are contraindicated during episodes of hypoglycemia and in patients sensitive to Humalog or one of its excipients.

Humalog differs from regular human insulin by its rapid onset of action as well as a shorter duration of action. Therefore, when used as a mealtime insulin, Humalog insulins (Humalog, Humalog Mix75/25, and Humalog Mix50/50) should be given within 15 minutes before a meal. Humalog can also be given immediately after a meal.

Due to the short duration of action of Humalog, patients with type 1 diabetes also require a longer-acting insulin to maintain glucose control (except when using an insulin pump). Glucose monitoring is recommended for all patients with diabetes.

The safety and effectiveness of Humalog in patients less than 3 years of age have not been established. Safety and effectiveness of Humalog Mix75/25 and Humalog Mix50/50 in patients less than 18 years of age have not been established. There are no adequate and well-controlled clinical studies of the use of Humalog insulins in pregnant or nursing women.

Starting or changing insulin therapy should be done cautiously and only under medical supervision.

Patients should be advised not to mix Humalog Mix75/25 or Humalog Mix50/50 with another insulin.

Hypoglycemia
Hypoglycemia is the most common adverse effect associated with insulins, including Humalog insulins. Hypoglycemia can happen suddenly, and symptoms may be different for each person and may change from time to time. Severe hypoglycemia can cause seizures and may be life-threatening.

Other Side Effects
Other potential side effects associated with the use of insulins include: hypokalemia, weight gain, lipodystrophy, and hypersensitivity. Systemic allergy is less common, but may be life-threatening. Because of the difference in action of Humalog insulins, care should be taken in patients in whom hypoglycemia or hypokalemia may be clinically relevant (e.g., those who are fasting, have autonomic neuropathy or renal impairment, are using potassium-lowering drugs, or taking drugs sensitive to serum potassium level).

Pumps
When used in an external insulin pump, Humalog should not be diluted or mixed with any other insulin. Humalog administration in insulin pumps has not been studied in patients with type 2 diabetes. The infusion set and Humalog should be replaced and a new infusion site selected every 48 hours or less. Glucose monitoring is particularly important for patients using an external insulin pump. Humalog in the external insulin pump should not be exposed to temperatures above 37°C (98.6°F).

Humalog was tested in the MiniMed® Models 506, 507, and 508 insulin pumps using MiniMed® Polyfin® infusion sets. Humalog was also tested in Disetronic® H-TRONplus® V100 insulin pump (with plastic 3.15 mL insulin reservoir), and the Disetronic D-TRON® and D-TRONplus® insulin pumps (with Humalog 3 mL cartridges) using Disetronic Rapid® infusion sets.

A Humalog 3 mL cartridge used in the D-TRON or D-TRONplus should be discarded after 7 days, even if it still contains Humalog. The infusion set (reservoir syringe, tubing, catheter), D-TRON or D-TRONplus cartridge adapters, and Humalog in the external insulin pump reservoir should be discarded every 48 hours or less.

For additional safety profile and other important prescribing considerations, see the Humalog, Humalog Mix75/25, and Humalog Mix50/50 Prescribing Information.

Humalog, Humalog Mix75/25, and Humalog Mix50/50 are available by prescription only.

Humalog Prescribing Information | Humalog Mix75/25 Prescribing Information | Humalog Mix50/50 Prescribing Information |
Humalog Patient Information
| Humalog Mix75/25 Patient Information | Humalog Mix50/50 Patient Information